CONMED Profit Margin 2010-2023 | CNMD

Current and historical gross margin, operating margin and net profit margin for CONMED (CNMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. CONMED net profit margin as of September 30, 2023 is 4.96%.
CONMED Annual Profit Margins
CONMED Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $3.346B $1.045B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.790B 19.12
McKesson (MCK) United States $60.273B 16.42
Cardinal Health (CAH) United States $25.943B 16.60
West Pharmaceutical Services (WST) United States $25.825B 43.52
Labcorp (LH) United States $17.922B 14.30
Cooper (COO) United States $16.740B 27.98
Align Technology (ALGN) United States $16.485B 36.11
Henry Schein (HSIC) United States $8.959B 13.59
DENTSPLY SIRONA (XRAY) United States $6.343B 16.18
Merit Medical Systems (MMSI) United States $4.147B 24.02
Patterson (PDCO) United States $3.070B 12.86
STAAR Surgical (STAA) United States $1.697B 77.24
Atrion (ATRI) United States $0.535B 25.16
Lifevantage (LFVN) United States $0.074B 18.87
Pro-Dex (PDEX) United States $0.062B 20.41
Biolase (BIOL) United States $0.003B 0.00